ANIP
HEALTHCAREANI Pharmaceuticals Inc
$84.06-0.57 (-0.67%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ANIP Today?
No stock-specific AI insight has been generated for ANIP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$56.71$99.50
$84.06
Fundamentals
Market Cap$1.9B
P/E Ratio25.3
EPS$3.32
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume269K
Avg Volume (10D)—
Shares Outstanding22.8M
ANIP News
21 articles- ANI Pharmaceuticals Inc (ANIP) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·May 9, 2026
- ANI Pharmaceuticals, Inc. (ANIP): A Small Cap Value Stock Capitalizing on Generic Drugs OpportunitiesYahoo Finance·May 8, 2026
- 3 Stocks Showing Powerful Earnings Acceleration This MayYahoo Finance·May 8, 2026
- ANI Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- ANI Pharmaceuticals (ANIP) shares jump after earnings beat and higher outlookAdvfn·May 8, 2026
- ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to SayYahoo Finance·May 8, 2026
- ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue EstimatesYahoo Finance·May 8, 2026
- ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q1 CY2026, Stock SoarsYahoo Finance·May 8, 2026
- ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial GuidanceYahoo Finance·May 8, 2026
- Gyre Therapeutics, Inc. (GYRE) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- ImmunityBio to Report Q1 Earnings: What's in the Cards?Yahoo Finance·May 4, 2026
- BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?Yahoo Finance·May 4, 2026
- Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?Yahoo Finance·May 4, 2026
- ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy?Yahoo Finance·May 1, 2026
- These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarYahoo Finance·May 1, 2026
- ANI Pharmaceuticals (ANIP) Announces Launch of Pimozide Tablets 1 mg and 2 mgYahoo Finance·May 1, 2026
- Zacks.com featured highlights include Mirion Technologies, Intuit and ANI PharmaceuticalsYahoo Finance·Apr 29, 2026
- NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLAYahoo Finance·Apr 28, 2026
- Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?Yahoo Finance·Apr 28, 2026
- Assessing ANI Pharmaceuticals (ANIP) Valuation After New U.S. Generic Drug LaunchesYahoo Finance·Apr 27, 2026
- ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025The Motley Fool·Mar 27, 2026
All 21 articles loaded
Price Data
Open$85.00
Previous Close$84.63
Day High$86.17
Day Low$84.01
52 Week High$99.50
52 Week Low$56.71
52-Week Range
$56.71$99.50
$84.06
Fundamentals
Market Cap$1.9B
P/E Ratio25.3
EPS$3.32
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume269K
Avg Volume (10D)—
Shares Outstanding22.8M
About ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—